Mitoscreening platform (MSP)

Switzerland
Malters, Lucerne, Switzerland

Company profile

Mitoscreening platform (MSP) company profile

Mitoscreening platform (MSP) is used to screen metabolism-targeting anti-cancer drugs to discover.

Business identity

Operating status
Active
Company type
For Profit

Headquarters

Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
1
Last funding
Grant / $9,813 / 2019-04-30
Investors
1
Lead investors
1

Founders and investors

Lead investors

Venture Kick

Investors

Venture Kick